Načítá se...
ViruClear: Molecularly designed biomimetic nanosponges for prevention and treatment of SARS‐CoV‐2 infections in COVID‐19 patients
The current COVID‐19 pandemic infectious disease agent SARS‐CoV‐2, like its’ cousin SARS‐CoV, uses a variety of entry receptors including angiotensin converting enzyme‑2 (ACE2), L‐SIGN (CD209L), and DC‐SIGN and others. The interaction between SARS‐CoV‐2 spike protein and host cell proteins is the fi...
Uloženo v:
| Vydáno v: | FASEB J |
|---|---|
| Hlavní autoři: | , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
The Federation of American Societies for Experimental Biology
2021
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8239890/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1096/fasebj.2021.35.S1.04581 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|